From Business Insider:
Atai Life Sciences, a psychedelic company backed by billionaire investor Peter Thiel, is eyeing a potential public stock listing as soon as this Spring, reports say.
The biotech company on Wednesday announced that it had raised a $157 million funding round from existing and new investors. Since it was founded in 2018, Atai has raised $367 million from 35 investors, according to PitchBook data.
The company develops "psychedelic and non-psychedelic compounds for various mental health indications," including depression and anxiety, according to the press release. Its mission has attracted some big-money investors, including Peter Thiel's Thiel Capital.
Thiel, a billionaire venture capitalist who famously—and lucratively—made a ground-floor investment in Facebook's early days, saw his firm Palantir go public last year. The firm is now worth nearly $45 billion....
....MORE
On March 1 FT Alphaville directed our attention to a story at sifted:
European companies set to dominate psychedelics market
that had a few more names of wannabe players.Totally unrelated:
"Her Royal Highness?... Magic mushrooms at Buckingham Palace"
